PROFIL KADAR SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (suPAR) PADA SERUM PENDERITA TUBERKULOSIS PARU (SEBAGAI MONITORING TERAPI)

Authors

  • Triwahju Astuti Laboratorium Ilmu Penyakit Paru Fakultas Kedokteran Universitas Brawijaya – RSU. Dr.Saiful Anwar Malang
  • Tri Yudani MR Laboratorium Biokimia-Biomolekuler Fakultas Kedokteran Universitas Brawijaya Malang
  • Wibi Riawan Laboratorium Biokimia-Biomolekuler Fakultas Kedokteran Universitas Brawijaya Malang
  • Nunuk Sri Muktiati Laboratorium Ilmu Penyakit Paru Fakultas Kedokteran Universitas Brawijaya – RSU. Dr.Saiful Anwar Malang
  • Edy Widjajanto Laboratorium Patologi Klinik Fakultas Kedokteran Universitas Brawijaya – RSU. Dr.Saiful Anwar Malang

DOI:

https://doi.org/10.21776/ub.jkb.2008.024.01.4

Abstract

Dutch study shows that Upar expression content is significantly higher in tubercolusis patient’s psiphsy monosit compared to those in the healthy control group. So far, there is no biologic marker used whichcan accurately observe response improvement in the treatment of lung tubercolusis. The aim of this research is to investigate whether the serum level of soluble utokinase plasminogen activator receptor (suPAR) carries information in monitoring TB treatment for Lung Tuberculosis patients. suPAR was measured by ELISA in 21 individuals at the time of enrolment into observational cross sectional based on active tuberculosis  and 5 individuals as healthy control. There were 3 groups, 1). patients who had not started treatment (n=7),2). patients who had been treated for 2 months (n=7),  3). patients who had been treated for 6 months (n=7). Among groups, there were no difference in mean of body mass index, erythrocyte sedimentation rate and monocyte count. Patients positive for TB on direct  microscopy were 29% ( 6 from 21 patients) , 2 patients each groups. The suPAR levels were elevated in patients with active TB compared to healthy control (P<0,001). suPAR levels were highest in patients positive for TB on direct microscopy ( mean suPAR 4.455 ng/ml).

Downloads

Download data is not yet available.

References

Perhimpunan Dokter Paru Indonesia. Pedoman Diagnosis Dan Penatalaksanaan di Indonesia. Jakarta: Indah Offset Citra Grafika, 2006. h. 1-64.

Chandrawati H. Hubungan Body Mass Index dan lajuendap darah (LED) pada penderita tuberkulosis paru sesudah pengobatan antituberkulosis 6 bulan. Malang: Universitas Brawijaya, 2006. h. 42-52.

Sidenius N, Sier CFM, Ullum H, Pedersen BK, Lepri AC, Blasi F, et al. Serum level of soluble urokinase-type plasminogen activator receptor of survival in human immunodeficiency virus infection. The America Society of Hematology 2000: 4091-4095.

Siawaya. JFB, Ruhwald M, Eugen-Olsen J, Walzi G,Correlates for disease progression and prognosis during concurrent HIV/TB infection. International Journal of Infectious Diseases, 2007, 11 : 289-299

Olsen JE, Gustafson P, Sidenius N, Fischer TK, Parner J, Aaby P.The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predict mortality during treatment: a community study from Guinea-Bissau.Int J Tuberc Lung Dis 2002; 6(8):686-692.

Schlesinger LS. Phagocytosis and toll-like receptor in tuberculosis. In: Rom WN, Garay SM. Tuberculosis. Philadelphia: Lippincott Williams and Wilkins; 2004. p. 203-209.

GML, Rom WN, Ciotoli C, Talbot A, Martiniuk F, Cronstein B, et al. Mycobacterium tuberculosis alters expression of adhesion molecules on monocytic cells. Infection and Immunity. 1994; 62: 2515-2520.

Ramirez GML, Rom WN, Ciotoli C, Talbot A, Martiniuk F, Cronstein B, et al. Mycobacterium tuberculosis alters expression of adhesion molecules on monocytic cells. Infection and Immunity. 1994; 62: 2515-2520.

Basuki SA, Pradjoko I. Perbandingan Efektifitas Penegakan Diagnosis Tuberkulosis Paru Melalui Metode Pengumpulan Dahak Sewaktu-Pagi-Sewaktu (SPS) dan Pagi-Pagi-Pagi (PPP) Pada Penderita Rawat Inap Di RSU Dr.Soetomo. Konker XI PDPI 2007. 177-181.

Juffermans NP, Dekkers PEP, Verbon A, Speelman,Deventer SJH, Poll T. Concurrent upregulation of urokinase plasminogen activator receptor and CD11b during Tuberculosis and experimental endotoxemia Infection and Immunity. 2001; 69: 5182-5185.

Juffermans NP, Verbon A, Speelman, Deventer SJH, Poll T. Elevated chemokine concentrations in seraof human immunodeficiency virus (HIV)-seropositive andHIV-seronegative patiens with Tuberculosis: a possible role for mycobacterial lipoarabinomannan. Infection and Immunity. 1999; 67: 4295-4297

Downloads

Published

2013-04-29

Issue

Vol. 24 No. 1 (2008)

Section

Research Article

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

Most read articles by the same author(s)